A recent publication using Prospections real world data analytics shows, 1 in 5 Australian patients with schizophrenia [1], is medicated with older typical long acting injectable (LAI) antipsychotics. With schizophrenia being one of the ...
Media Release Prospection and Novotech Partner Sydney, 25 January 2022 – Global healthcare data technology company, Prospection, and leading Asia-Pacific biotech specialist CRO, Novotech Health Holdings, announce an strategic partnership...
Creating real world insights and visualising where and when there is opportunity to improve the treatment experience. We supports clients in their quest to make a positive impact on patient experience. Answering questions like:– Wh...
A Prospection Podcast with Dr Peter Cronin. What does it mean to be a trusted 3rd party provider? Prospection operates as an intermediary between data custodians and end users of the data. Finding elements in...
Exploring the field of real world evidence generation. How turning real world data into evidence is improving the patient outcomes. A Prospection Podcast series In this episode, we dive into the concept of finding patients...
Prospection, has successfully raised $45 million from institutional investors in a Series B round. Corner stoned by new investor Ellerston JAADE with participation from existing shareholders Main Sequence and Horizons Ventures. Pro...
An estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths occurred Worldwide in 2020 (GLOBOCAN 2020). In Australia, cancer is the leading cause of health burden. More than 1 million people in...
Rare disease Day, recognises the 6,000+ identified, often life threatening, rare diseases*. Impacting over 300 million people worldwide, 72% of rare diseases are genetic, with 70% of those starting in childhood*. The low prevalence and...
Quarterly Recognition Awards At Prospection we believe that our values drive our behaviours and they’re what make all of us stand out from the crowd. This week we celebrated the incredible contributions from our whole...
Prospection integrate and analyse a range of data that includes administrative claims data, electronic medical records, hospital and insurance data and other big data sets. The integration and analysis of this data provides real world...
PharmDash is a real-world evidence platform that delivers insights into the use, value, and outcomes of different medications across all disease areas. Initially designed to work with the Australian Pharmaceutical Benefits Scheme (...
Today, we announce the opening of our Japan headquarters. With the appointment of health informatics and pharmaceutical veteran Kaoru Sato to lead our Japan operations. The new office in Tokyo will enable Prospection to work closely wit...
PharmMap provides geospatial data insights through integration of multiple health datasets. Purpose built to assist life science companies, PharmMap is a prominent tool within the Prospection product portfolio. It integrates operational ...
Prospection has developed into a company that clients can trust to help them achieve success. Our advanced knowledge and expertise in healthcare data analytics supports complex research questions. The experience and expertise of the 3 f...
Prospection is a health data analytics company that is currently based in Sydney. In the beginning Prospection started with just 3 people, its founders Eric, Ricky and Peter. 8 years on Prospection has thrived, growing...
The global COVID-19 pandemic brings into sharp focus how timely access to linked datasets supports more efficient decision making. Australia was lauded for its management of the global health challenge with so few lives lost....
Real world data provides patient and disease insights. Prospection Co-founders, Eric Chung, CEO and Dr Peter Cronin, Head of Data & Partnerships, joined Techwire Asia’s, ‘Tech Means Business‘ podcast with Joe Green....
